Free National NPI Number Registry

Dr. Peter J Riznyk

Home >Dr. Peter J Riznyk

 

NPI Number Detailed Information

Provider Information:

Name: Dr. Peter J Riznyk
Gender: M
Provider License Number If Given: 4194

NPI Information:

NPI: 1730168667
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 1/10/2006

Last Update Date: 10/29/2007

Reputation Report:

Provider Business Mailing Address:

Address: 6272 W QUAKER ST
Orchard Park, NY 14127
Phone Number: 7166627729
Fax Number: 7166621822

Provider Business Practice Location Address:

Address: 6272 W QUAKER ST
Orchard Park, NY 14127
Phone Number: 7166627729
Fax Number: 7166621822

Provider Taxonomy:

Primary: 213ES0000X
Secondary (if any): 213ES0103X
State: NY

Top Doctors in NY

 

About Dr. Peter J Riznyk

Dr. Peter J Riznyk (DR. PETER J RIZNYK ) is Definition Podiatrist Physician in Orchard Park, NY. The NPI Number for Dr. Peter J Riznyk is 1730168667.
The current location address for Dr. Peter J Riznyk is 6272 W QUAKER ST Orchard Park, NY 14127 and the contact number is 7166627729 and fax number is 7166621822. The mailing address for Dr. Peter J Riznyk is 6272 W QUAKER ST Orchard Park, NY 14127- 7166627729 (mailing address contact number - 7166627729).
Definition to come...

Provider Business Location on Map

FAQs:

What is the NPI Number for Dr. Peter J Riznyk ?


Answer: The NPI Number for Dr. Peter J Riznyk is 1730168667

Where is Dr. Peter J Riznyk located?


Answer: Dr. Peter J Riznyk is located at 6272 W QUAKER ST Orchard Park, NY 14127.

What is the specialty for Dr. Peter J Riznyk ?


Answer: The Specialty of Dr. Peter J Riznyk is Definition Podiatrist Physician.

Are there any online reviews for Dr. Peter J Riznyk ?


Answer: Yes! Check It Now.

Are there any other health care providers in Orchard Park, NY?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Peter J Riznyk

Number of HCPCS 42
Number of Medicare Beneficiaries 502
Number of Services 2201
Total Submitted Charge Amount 149793.75
Total Medicare Allowed Amount 92785.32
Total Medicare Payment Amount 64997.2
Total Medicare Standardized Payment Amount 66738.45
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 1
Number of Medicare Beneficiaries With Drug Services 25
Number of Drug Services 282
Total Drug Submitted Charge Amount 846
Total Drug Medicare Allowed Amount 43.08
Total Drug Medicare Payment Amount 30.04
Total Drug Medicare Standardized Payment Amount 29.34
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 41
Number of Medicare Beneficiaries With Medical 502
Number of Medical Services 1919
Total Medical Submitted Charge Amount 148947.75
Total Medical Medicare Allowed Amount 92742.24
Total Medical Medicare Payment Amount 64967.16
Total Medical Medicare Standardized Payment Amount 66709.11
Average Age of Beneficiaries 72
Number of Beneficiaries Age Less 65 115
Number of Beneficiaries Age 65 to 74 172
Number of Beneficiaries Age 75 to 84 147
Number of Beneficiaries Age Greater 84 68
Number of Female Beneficiaries 258
Number of Male Beneficiaries 244
Number of Non-Hispanic White Beneficiaries 466
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified 16
Number of Beneficiaries With Medicare & Medicaid Entitlement 178
Number of Beneficiaries With Medicare Only Entitlement 324
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.12
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.16
Percent (%) of Beneficiaries Identified With Asthma 0.07
Percent (%) of Beneficiaries Identified With Cancer 0.13
Percent (%) of Beneficiaries Identified With Heart Failure 0.19
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.41
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.14
Percent (%) of Beneficiaries Identified With Depression 0.25
Percent (%) of Beneficiaries Identified With Diabetes 0.43
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.71
Percent (%) of Beneficiaries Identified With Hypertension 0.69
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.32
Percent (%) of Beneficiaries Identified With Osteoporosis 0.15
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.44
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders 0.08
Percent (%) of Beneficiaries Identified With Stroke 0.04
Average HCC Risk Score of Beneficiaries 1.5025

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Podiatry
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 490
Number of Standardized 30-Day Fills 560.06666667
Aggregate Cost Paid for All Claims 6729.26
Number of Day's Supply for All Claims 13335
Number of Medicare Beneficiaries 261
Number of Claims, Including Refills, for Beneficiaries Age 65+ 403
Including Refills, for Beneficiaries Age 65+ 463.9
Beneficiaries Age 65+ 5569.46
Number of Day's Supply for All Claims for Beneficaries Age 65+ 10998
Number of Medicare Beneficiaries Age 65+ 219
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst *
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 482
Aggregate Cost Paid for Generic Drugs 6643.97
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst #
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 308
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 3359.6
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 182
Aggregate Cost Paid for Claims Filled by 3369.66
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 136
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 2171.16
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 354
by Low-Income Subsidy 4558.1
Total Claims of Opioid Drugs, Including 36
Aggregate Cost Paid for Opioid Drugs 143.2
Opioid Claims 32
Opioid_Tot_Clms divided by the Tot_Clms 7.3469387755
Total Claims of Long-Acting Opioid Drugs 0
Aggregate Cost Paid for Long-Acting Opioid 0
Number of Day's Supply of All Long-Acting 0
Long-Acting Opioid Claims 0
Opioid_LA_Tot_Clms divided by the 0
Total Claims of Antibiotic Drugs, Including 62
Aggregate Cost Paid for Antibiotic Drugs 577.23
Antibiotic Claims 47
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims 0
Average Age of Beneficiaries 71.298850575
Number of Beneficiaries Age Less Than 65 42
Number of Beneficiaries Age 65 to 74 117
Number of Beneficiaries Age 75 to 84 75
Number of Female Beneficiaries 136
Number of Male Beneficiaries 125
Number of Non-Hispanic White 246
Number of Black or African American
Number of Asian Pacific Islander 0
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement 205
Average Hierarchical Condition Category 1.3564407611

More Providers in orchard-park , ny

Dr. peter J riznyk in Other Directories

Provider don't have other directory link yet.